Terms: = Skin cancer AND XPO1, DKFZp686B1823, 7514, ENSG00000082898, O14980, CRM1 AND Treatment
6 results:
1. Effect of selinexor on lipogenesis in virus-positive Merkel cell carcinoma cell lines.
Landes JR; Bartley BR; Moore SA; He Q; Simonette R; Rady PL; Doan HQ; Tyring SK
Clin Exp Dermatol; 2023 Jul; 48(8):903-908. PubMed ID: 37191210
[TBL] [Abstract] [Full Text] [Related]
2. The efficacy of selinexor (KPT-330), an xpo1 inhibitor, on non-hematologic cancers: a comprehensive review.
Landes JR; Moore SA; Bartley BR; Doan HQ; Rady PL; Tyring SK
J Cancer Res Clin Oncol; 2023 May; 149(5):2139-2155. PubMed ID: 35941226
[TBL] [Abstract] [Full Text] [Related]
3. Selinexor is a novel inhibitor of DNA damage response in Merkel cell carcinoma.
Moore SA; Narayanan D; Simonette RA; Bartley BR; Doan HQ; Rady PL; Tyring SK
Clin Exp Dermatol; 2022 Jul; 47(7):1354-1357. PubMed ID: 35120268
[TBL] [Abstract] [Full Text] [Related]
4. Hypertrophic lichenoid dermatitis immune-related adverse event during combined immune checkpoint and exportin inhibitor therapy: A diagnostic pitfall for superficially invasive squamous cell carcinoma.
Marques-Piubelli ML; Tetzlaff MT; Nagarajan P; Duke TC; Glitza Oliva IC; Ledesma DA; Aung PP; Torres-Cabala CA; Wistuba II; Prieto VG; Nelson KC; Curry JL
J Cutan Pathol; 2020 Oct; 47(10):954-959. PubMed ID: 32394425
[TBL] [Abstract] [Full Text] [Related]
5. Nuclear export of cutaneous HPV8 E7 oncoprotein is mediated by a leucine-rich nuclear export signal via a crm1 pathway.
Onder Z; Chang V; Moroianu J
Virology; 2015 Jan; 474():28-33. PubMed ID: 25463601
[TBL] [Abstract] [Full Text] [Related]
6. A comparison of the activity, sequence specificity, and crm1-dependence of different nuclear export signals.
Henderson BR; Eleftheriou A
Exp Cell Res; 2000 Apr; 256(1):213-24. PubMed ID: 10739668
[TBL] [Abstract] [Full Text] [Related]
